{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F10182019-ablative-arbitration-jYfSVLt3","width":444,"version":"1.0","type":"rich","title":"10.18.2019 - Ablative Arbitration","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/8cea0cba-61b3-444d-a25a-5b8648805524\" height=\"200\" width=\"100%\" title=\"10.18.2019 - Ablative Arbitration\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Prostate SBRT boost, Intratumor Heterogeneity, Twitter or Twit-him?, Wise Choices\n\nquadshotnews@gmail.com\n@QuadShotNews"}